Sklar R M, Beggs A H, Lev A A, Specht L, Shapiro F, Brown R H
Cecil B. Day Neuromuscular Research Laboratory, Massachusetts General Hospital, Charlestown 02129.
Neurology. 1990 Dec;40(12):1854-8. doi: 10.1212/wnl.40.12.1854.
We examined normal and dystrophic human myotubes in cell culture for expression of dystrophin, the protein product of the Duchenne muscular dystrophy locus. Dystrophin levels in developing myotubes detected by Western blotting increased after 24 hours and reached maximum levels after 10 days in fusion medium. We did not detect dystrophin in myotubes cultured from Duchenne myoblasts (7 cases). Myotubes from a Becker muscular dystrophy patient's biopsy produced a lower molecular weight (approximately 408 kd) dystrophin, which was the same size in a whole muscle preparation from the same biopsy. This 408-kd dystrophin was the expected size for this Becker patient whose DNA was deleted for exons 45-48 of the Duchenne gene. This cell culture system will allow a detailed analysis of the effects of potential pharmacologic agents on steady-state dystrophin levels.
我们在细胞培养中检测了正常和营养不良的人肌管中抗肌萎缩蛋白(杜氏肌营养不良基因座的蛋白质产物)的表达情况。通过蛋白质免疫印迹法检测发现,发育中的肌管中抗肌萎缩蛋白水平在24小时后升高,并在融合培养基中培养10天后达到最高水平。我们在来自杜氏成肌细胞(7例)培养的肌管中未检测到抗肌萎缩蛋白。一名贝克型肌营养不良患者活检组织培养的肌管产生了较低分子量(约408 kd)的抗肌萎缩蛋白,在同一次活检的整块肌肉标本中其大小相同。这种408-kd的抗肌萎缩蛋白是该贝克型患者的预期大小,其DNA缺失了杜氏基因的45-48号外显子。这个细胞培养系统将能够详细分析潜在药物制剂对稳态抗肌萎缩蛋白水平的影响。